Cancer drug listing

Drug name(s)

Orencia® Abatacept

Approved for

• Other Blood Cancers

Drug name(s)

Calquence® Acalabrutinib

Approved for

• Chronic Lymphocytic Leukemia (CLL/SLL)
• Lymphoma

Drug name(s)

Campath® Alemtuzumab

Approved for

• Leukemia
• Chronic Lymphocytic Leukemia (CLL/SLL)

Drug name(s)

Agrylin® Anagrelide hydrochloride

Approved for

• Myeloproliferative Neoplasms (MPN)
• Essential Thrombocythemia

Drug name(s)

Trisenox® Arsenic trioxide

Approved for

• Leukemia
• Acute promyelocytic leukemia (APL)

Drug name(s)

Scemblix® Asciminib

Approved for

• Leukemia
• Chronic Myeloid Leukemia (CML)
• Other Blood Cancers

Drug name(s)

Asparaginase

Approved for

• Leukemia
• Acute Lymphoblastic Leukemia (ALL)

Drug name(s)

Asparaginase erwinia chrysanthemi (recombinant)- rywn Rylaze®

Approved for

• Acute Lymphoblastic Leukemia (ALL)
• Lymphoblastic Lymphoma

Drug name(s)

Ayvakit® Avapritinib

Approved for

• Leukemia
• Other Blood Cancers

Drug name(s)

Axatilimab-csfr Niktimvo™

Drug name(s)

Yescarta® Axicabtagene ciloleucel

Approved for

• Lymphoma
• Diffuse Large B-cell Lymphoma (DLBCL) 
• Follicular Lymphoma (FL) 

Drug name(s)

Vidaza® Azacitidine Onureg®

Approved for

• Juvenile Myelomonocytic Leukemia (JMML)
• Myelodysplastic Syndromes (MDS)

Drug name(s)

Adcetris® Brentuximab vedotin

Approved for

• Leukemia
• T-Cell Prolymphocytic Leukemia
• Hodgkin Lymphoma (HL)
• Peripheral T-cell Lymphoma, Not Otherwise Specified (PTCL-NOS)
• Other Blood Cancers

Drug name(s)

Asparlas® Calaspargase pegol-mknl

Approved for

• Leukemia
• Acute Lymphoblastic Leukemia (ALL)

Drug name(s)

Aliqopa® Copanlisib

Approved for

• Lymphoma
• Follicular Lymphoma (FL) 

Drug name(s)

Cytosar-U® Cytosine arabinoside Ara-C Cytarabine Liposomal cytarabine DepoCyt®

Approved for

• Leukemia
• Acute Lymphoblastic Leukemia (ALL)
• Acute Myeloid Leukemia (AML)
• Chronic Myeloid Leukemia (CML)
• Lymphoma

Drug name(s)

Aranesp® Darbepoetin alfa

Approved for

• Other Blood Cancers

Drug name(s)

Adriamycin® Doxorubicin

Approved for

• Leukemia
• Acute Lymphoblastic Leukemia (ALL)
• Acute Myeloid Leukemia (AML)
• Lymphoma
• Hodgkin Lymphoma (HL)
• Non-Hodgkin Lymphoma (NHL)

Drug name(s)

Abecma® Idecabtagene vicleucel

Approved for

• Myeloma

Drug name(s)

Alkeran® Melphalan

Approved for

• Myeloma

Drug name(s)

Arranon® Nelarabine

Approved for

• Leukemia
• Acute Lymphoblastic Leukemia (ALL)
• Lymphoma

Drug name(s)

Aucatzyl® Obecabtagene autoleucel

Approved for

• Acute Lymphoblastic Leukemia (ALL)

Drug name(s)

Arzerra® Ofatumumab

Approved for

• Leukemia
• Chronic Lymphocytic Leukemia (CLL/SLL)

Drug name(s)

Aredia® Pamidronate

Approved for

• Myeloma
• Other Blood Cancers

Drug name(s)

Actemra® Tocilizumab

Approved for

• Other Blood Cancers

Drug name(s)

Vesanoid® ATRA Tretinoin All-trans retinoic acid (ATRA)

Approved for

• Leukemia
• Acute Myeloid Leukemia (AML)
• Acute promyelocytic leukemia (APL)